The analysis of different variations in genomics, transcriptomics, epigenomics and proteomics has increased considerably in recent years. This is especially due to the success of microarray and, more recently, sequencing technology. Apart from understanding mechanisms of disease pathogenesis on a molecular basis, e.g., in cancer research, the challenge of analyzing such different data types in an integrated way has become increasingly important also for the validation of new sequencing technologies with maximum resolution. 
Introduction
The areas of biomedical research often summarized as Omics, in particular genomics, transcriptomics, epigenomics and proteomics, have gained importance in recent years due to technological advances facilitating their analysis. Especially the success of microarrays has helped to use Omics data for understanding mechanisms of disease pathogenesis on a molecular basis, e.g., in cancer research. The increasing availability of data has lead to joint, mostly paired, analyses of various data types with the aim of combining information as well as validating results and conclusions based on single Omics data types. One example are joint analyses of copy number and gene expression data, i.e., of genomic and transcriptomic data (see, e.g., Ortiz-Estevez et al., 2011; van Wieringen & van de Wiel, 2009 ). The development and increasing importance of nextgeneration sequencing technologies, which in principle provide maximum resolution without restriction to a fixed number of probes at which information is gathered, is creating the need for a further type of joint analyses: Assessing the accuracy and consistency of results from microarray platforms and next-generation sequencing when targeting the same molecular biologic questions.
In epigenomics, modifications of histones -proteins around which the DNA winds -are an important focus of research because such histone modifications may activate or inhibit the expression of genes and analyzing their functioning may thus help to understand the cause of genetic diseases. Chromatin immunoprecipitation (ChIP) is a molecular biologic method to assay histone modifications; in ChIP, specific antibodies are used to select modified histones together with DNA fragments wound around the histones. Then, DNA fragments are isolated from the histones. In order to determine the genomic positions of the modified histones, the genomic positions of the DNA fragments have to be determined. This can be carried out by labelling the DNA fragments with fluorescent dye, hybridizing them to a microarray containing millions of small fixed DNA sequences and deducing the amount of hybridized DNA from intensitiy values measured with a scanner (ChIP-chip, see Mockler & Ecker, 2005) .
Alternatively, the DNA fragments can be sequenced directly using next-generation sequencing technologies and compared to a reference genome (ChIP-seq, see Park, 2009 ).
A number of methods have been introduced for analysis of both ChIP-chip and ChIP--2 --seq data (e.g., Mo and Liang, 2010; Kuan et al., 2011) , but work on the joint analysis of these two inputs is still essentially missing, with the exception of Ho et al. (2011) (Vega et al., 2009 ).
The simultaneous comparison of two different variables and two collectives has been tackled in bioinformatics literature, at least implicitly by using ratios calculated from two collectives for both variables (see, e.g., Gallegos et al., 2008) . Schäfer et al. (2009) address this setting most explicitly and develop an externally centered correlation coefficient for the simultaneous analysis of two data inputs, using the example of gene expression and copy number data, on two different collectives representing cancer patients and normal controls.
In this work, an adaptation of this framework for the comparison of microarray and sequencing results is developed. With the help of Bayesian methodology, we are able to distinguish between loci at which both biotechnologies agree and loci where they disagree. We demonstrate the utility of our approach on a murine cell line which was transduced with BCR-ABL, an oncogene supposedly responsible for a specific subtype of leukemia.
Data
The data for the comparison were derived from a 32D cell line that was originally -3 --isolated from murine bone marrow.
At the University Hospital of Münster, 32D cells were retrovirally stably transduced with the oncogene BCR-ABL (Elling et al., 2011) , which is the hallmark of chronic myeloid leukemia (CML). Further, 32D cells were mock-transduced with the empty vector and used as a control sample. BCR-ABL is a fusion oncoprotein which arises from the genomic translocation t(9;22) and can be detected in different human leukemia patients, especially CML and Philadelphia-positive acute lymphoblastic leukemia.
The control cell line was treated with a growth factor in order to make control cells more similar to the cancer cells w.r.t. growth behaviour. Chromatin immunoprecipitation (ChIP) with an antibody against acetylated histone 3 at lysines 9 and 14 (antiH3K9Ac/K14Ac) was conducted, then the DNA material was amplified by polymerase chain reaction (PCR). The identity of the DNA sequences bound by the antibody was determined separately by ChIP-chip and ChIP-seq methods. While ChIP-chip is based on a fixed number of probes on fixed locations due to microarray design, ChIP-seq is not limited w.r.t. measurement loci and its precision is only limited by the sequencing depth, i.e., the number of matched sequences, defined by the analyst.
In ChIP-seq, the sequences of several million DNA fragments were determined by highthroughput-screening using the Illumina Genome Analyzer IIx. The origin of the short 35 bit pair (bp) sequences was determined by comparing the sequences with the Mus musculus reference genome. In case of our study, if many DNA sequences fall into a certain region, this indicates that the DNA fragments were bound to histones selected by the antibody during ChIP, and hence, the histones were acetylated in this region.
In ChIP-chip, the DNA fragments were labelled with fluorescent dye and hybridized to the Affymetrix GeneChip Mouse Promoter 1.0R array with approximately 4.5 million 25 mer probes covering more than 25000 promotors, i.e., genomic regions near the genes' transcriptional start sites. Subsequently, a scanner measured an intensity value for each probe. The measurement process was repeated three times on the same cells and the mean across the repeated measurements is taken for subsequent analysis.
The resulting data base in this study is thus very small, consisting of only two cell lines, with measurements taken by two different methods each.
Preprocessing
The ChIP-chip data were preprocessed using the R package Starr (Zacher et al., 2010) , -4 --in particular by performing quantile normalization (Bolstad et al., 2003) . For ChIP-seq data, we could align 5,452,964 (3,666,697) reads obtained from the BCR-ABL (control) sample to the reference. Duplicate sequences are likely artefacts from PCR and were removed, reducing the number of reads to 5,111,088 and 3,398,454, respectively. We then randomly deleted further reads in the BCR-ABL sample to get an equal number of reads there compared to the control sample in each chromosome and thus mimick equal sequencing depths. Sequences were aligned by the Burrows-Wheeler Alignment tool (Li & Durbin, 2009 ) using Mus musculus NCBI m37 as reference genome.
To match the ChIP-chip and ChIP-seq values, any ChIP-chip intensity value is assigned the amount of ChIP-seq sequences overlapping its probe, producing a continuous intensity value and an integer number per locus. For this purpose, we artificially Still, the matching comes at the cost of excluding some of the sequences from the analysis. Furthermore, sequencing depth in this study was rather small. The loci for which the ChIP-seq value is zero for both the BCR-ABL and the control cell line are therefore omitted for subsequent analysis since it is uncertain whether the absence of bound sequences is due to absence of acetylation or, rather, due to lack of sequencing depth. To avoid the potential interpretative problems connected to these experimental conditions, it appears acceptable to omit some loci. Due to memory limitations in fitting our Bayesian model with standard software, we restrict our analysis to chromosome 9 where in preliminary analyses a high number of overlapping sequences had been identified. This results in a total amount of 104672 loci. Schäfer et al. (2009) presented an externally centered correlation coefficient for the analysis of two sources of genetic variation on two different collectives, using gene expression and copy number data as example inputs. Specifically, the coefficient assesses the degree to which abnormalities are present in a cancer collective w.r.t. a -5 --control collective that are equally directed in the two data sources. Here, we propose to use this idea in a different setting where again two different collectives are given, but rather two techniques for measuring the same type of variation in Omics data are analysed instead of two different types of genetic variation. For this end, adaptations have to be made that are described in the following.
Adaptation of externally centered correlation coefficient
The externally centered correlation coefficient for two random vectors
, corresponding to two sets of measurements on m subjects, is defined as follows (Schäfer et al., 2009) :
where A and B are median values across reference samples, e.g., normal controls, for the two types of variation at the investigated locus. All measurements are on the 2 log -scale.
The measure EC r cannot be applied directly to the comparison of the ChIP-chip and
ChIP-seq data in this study since for each technology only one sample per biological condition is available (m = 1), and so, no type of correlation can be calculated.
However, the rectangles defined by the summands in the nominator, used by Schäfer et al. (2009) to construct a Wilcoxon test, remain well interpretable. We propose to employ them as a base measure for analysis; for their standardization a measure of dispersion is used not across samples, but instead across a window of fixed size around each locus i, containing loci , respectively. Since the loci in each window may be quite different in characteristics and also their numbers may vary considerably, we suggest to use a robust measure here that is less sensitive to such differences. A modified measure for the loci i=1,…,n inspired by the externally centered correlation coefficient can then
(1) 
Normal Bayesian mixture model
Bayesian normal mixture models have been used in microarray analysis for classifying genes into categories w.r.t., e.g., differential expression, being the target of a transcription factor or not, as well as for classifying copy number measurements into a number of distinct categories, like normal, loss and gain, representing each category by one of the mixing components (Bröet & Richardson, 2006 , Wei & Pan, 2008 
where j π is the probability of the jth group, j=1,…,J, and
is the probability density function of a normal distribution with mean j μ and variance Inverse Gamma(0.1,0.1) and
Dirichlet (1,1,1,1,1,1,1,1) .
Results
To fit the model, we use Markov Chain Monte Carlo (MCMC) methods implemented in -8 --the standard software WinBUGS (Spiegelhalter et al., 2003) . The corresponding code can be obtained from the authors upon request. For all other types of calculations and analyses, we use the statistical software environment R, version 2.14.1 (R Development Core Team, 2011) .
Since prior to ChIP, the DNA is cut into pieces of up to at least 1000bp in size and a maximum of approximately 150bp wraps around one histone, DNA fragments enriched by the ChIP procedure, i.e., an increased amount of DNA fragments bound to modified histones, can be found at up to roughly 900bp distance from an acetylated histone. Thus, we choose a window size of 1800bp for standardization in (1). Non-valid Z values due to, e.g., the denominator being equal to zero in the ChIP-seq part of equation (1) Table 1 . In Figure 1 , the overall fit of the model to the data can be seen. The visible peaks at -1 and 1 arise due to a certain number of loci for which no other loci fall into their standardizing window, which results in nominator and deminator being equal in terms of absolute value. As intended, components 1 to 3 and components 6 to 8 represent the negative and positive Z values, respectively, and component 5 represents the zero values. Component 4 comes to capture values that are close to zero.
[ Table 1 
Discussion
In this analysis we have compared the results obtained from ChIP-chip and ChIP-seq technologies, investigating histone modifications in a murine cell line into which the cancer gene BCR-ABL was transduced, compared to a normal control cell line. In addition to correlation methods which have been used for such kind of analyses, we have adapted the externally centered correlation coefficient (Schäfer et al., 2009 ) to capture the degree of concordance between the two technologies by an adequate measure, and subsequently applied a Bayesian mixture model to classify loci as presenting 'cancer-reference' value differences that are concordant or discordant between ChIP-chip and ChIP-seq measurements. The mixing proportions of the model components representing either concordant or discordant differences total around only 20%, while most values are estimated to be zero or near enough to zero to be explained by random variability. This may be due to the fact that the same antibody (antiH3K9Ac/K14Ac) was used for both the BCR-ABL and the control cell line, possibly leading to overly similar ChIP-seq profiles in both.
The sum of the mixing proportions of the model components representing concordant differences (0.131) is bigger than the sum of the mixing proportions of the model components representing discordant differences (0.073), i.e., in our analysis, ChIP-chip and ChIP-seq agree more often than they disagree. The credible intervals of the two sums of proportions suggest that they are significantly different from each other and from zero, but that the real difference between them might be smaller than suggested by -11 --the point estimates, which is why they should be interpreted with caution. From a practical viewpoint, it would be desirable that the proportion of differences judged as being discordant between ChIP-chip and ChIP-seq be smaller than indicated by the model, ideally not statistically different from zero. The considerable amount of discordances remains disturbing to researchers relying on validity of results.
However, for a number of reasons it can be questioned whether the results can be generalized w.r.t the amount of discordances. First, the control cell line probes were originally treated differently (with a growth factor for ChIP-seq, without a growth factor for ChIP-chip). Since different experimental conditions harm comparability, several months later new ChIP-chip profiles were generated, this time with a growth factor as well. The time between the two measurements may possibly have caused batch effects, whose impact in histone modification analyses has not yet been studied. The growth factor, on the other hand, while intended to increase comparability of the cell lines w.r.t. growth behaviour, may possibly also cause changes w.r.t. other cell characteristics. Also, the sequencing depth was rather small, which makes it likely that a number of low-and medium-size peaks in the sequencing data may not have been detected. Finally, as suggested by Ho et al. (2011) , the cross-platform validity of ChIP-chip and ChIP-seq measurements depends heavily on the used antibody, and precisely for anti-H3K9Ac, an antibody similar to the one used in our experiments, they report the worst results of all across several antibodies. In conclusion, it is possible that the experimental conditions have harmed the results in our study. One likely source of bias, the choice of an algorithm to perform peak calling on the ChIP-seq data (see again Ho et al., 2011) , was, however, eliminated in our analysis since we did not carry out peak calling. The results indicate that researchers should remain cautious at the moment w.r.t. the mutual reproducibility of ChIP-chip and ChIP-seq results.
The measure used here for assessing the concordance between ChIP-chip and ChIP-seq technologies can be readily adapted to take into account asymmetry w.r.t the two possible types of discordance between the two data types, i.e., cases where the ChIPchip value presents a positive deviation w.r.t the control collective and the ChIP-seq value a negative one should not be treated equal to the reverse case.
We demonstrated the utility of the presented methodological framework for jointly analyzing two data sources in presence of very small sample sizes, independently from Legends to the Tables   TABLE 1. Mean posterior estimates of model parameters (with their standard deviations) and numbers of assigned loci.
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